News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

OneWorld Health Safety and Efficacy Study of Kala-Azar Treatment in Bangladesh Moves Forward



12/22/2011 7:19:14 AM

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--OneWorld Health (OWH), a non-profit organization dedicated to developing lifesaving medicines for neglected diseases in children, announced completion of enrollment for an effectiveness study of Paromomycin Intramuscular Injection (PMIM) as a treatment for visceral leishmaniasis (VL or kala-azar) in Bangladesh. With 120 patients enrolled, the study is investigating the safety and efficacy of treatment of kala-azar with PMIM mono-therapy in VL-endemic areas of the country.

Read at BioSpace.com

Related News

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES